Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andreu Vilaseca"'
Autor:
Sunny Malhotra, Nicolas Fissolo, Carmen Rodríguez‐Rivera, Enric Monreal, Marta Montpeyo, Elena Urcelay, Juan Carlos Triviño, María José Pérez‐García, Miguel F. Segura, Agustín Pappolla, Jordi Río, Andreu Vilaseca, José Ignacio Fernández Velasco, Andrés Miguez, Carlos Goicoechea, Marta Martinez‐Vicente, Luisa M Villar, Xavier Montalban, Manuel Comabella
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 4, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/c4c6c2fc280e4866a272562127ef32f3
Autor:
Cristina Arnaldos-Pérez, Andreu Vilaseca, Laura Naranjo, Lidia Sabater, Josep Dalmau, Raquel Ruiz-García, Francesc Graus
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
SOX1 antibodies (SOX1-abs) are associated with paraneoplastic neurological syndromes (PNS) and small cell lung cancer (SCLC). In many clinical laboratories SOX1-abs are determined by commercial line blots without confirmation by cell-based assay (CBA
Externí odkaz:
https://doaj.org/article/1140f049d5ca4f9e838ba96d8dc5f7f2
Autor:
Andreu Vilaseca, Le-Duy Do, Ramona Miske, Nicolás Lundahl Ciano-Petersen, Laura Khatib, Macarena Villagrán-García, Antonio Farina, Véronique Rogemond, Lars Komorowski, David Gonçalves, Bastien Joubert, Jérôme Honnorat
Publikováno v:
Journal of Neurology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc98a275b8f7be72c55f43381994b998
https://doi.org/10.1007/s00415-023-11732-z
https://doi.org/10.1007/s00415-023-11732-z
Autor:
Eva Catalá, Gloria Iacoboni, Ángela Vidal‐Jordana, Gerard Oristrell, Cecilia Carpio, Andreu Vilaseca, Alba Cabirta, Francesc Bosch, Mar Tintoré, Pere Barba
Publikováno v:
Hematological Oncology. 40:482-487
The advent of chimeric antigen receptor (CAR) T-cell therapy has changed the therapeutic landscape of relapsed/refractory aggressive B-cell lymphomas. Cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome (ICANS) are th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52fe99f68786382ce0cd6d7dfe4a9d60
https://doi.org/10.1002/hon.2976
https://doi.org/10.1002/hon.2976
Autor:
Elena Fonseca, Andreu Vilaseca, Laura Abraira, Manuel Quintana, Manuel Toledo, José Alvarez-Sabín, Carla Anciones Martín, Estevo Santamarina, Antonio Gil-Nagel, Iván Seijo-Raposo
Publikováno v:
Seizure. 89
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06980ee4d83ef0bed06d12f67dad758d
https://pubmed.ncbi.nlm.nih.gov/34015572
https://pubmed.ncbi.nlm.nih.gov/34015572
Autor:
Carlos A. Molina, Marc Ribó, Manuel Requena, Alejandro Tomasello, Andreu Vilaseca-Jolonch, Pablo Guijarro, Valeska Seguel
Publikováno v:
Stroke. 52
Background and purpose: Direct transfer to angiosuite (DTAS) has consistently shown to be effective and safe shortening in-hospital workflows and encouraging long-term outcome benefits. In order to generalize DTAS an organizational and manpower effor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3aa810e2bb1e9d103468b540871eb8b7
https://doi.org/10.1161/str.52.suppl_1.p134
https://doi.org/10.1161/str.52.suppl_1.p134
Autor:
Manel Santafé, Manuel Toledo-Argany, Anna Sanchez Corral, Lorena Guzmán, Manuel Quintana, María Sueiras, Rosa Maria Gràcia Gozalo, Andreu Vilaseca, Edoardo Caronna, Estevo Santamarina
Publikováno v:
Acta neurologica ScandinavicaREFERENCES. 142(6)
OBJECTIVE To evaluate long-term prognosis in patients with refractory status epilepticus according to the level of sedation reached during drug-induced coma. MATERIALS AND METHODS Longitudinal study of patients with status epilepticus who received an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f55e67daa004d5e6c7d714a76fbc4884
https://pubmed.ncbi.nlm.nih.gov/32614067
https://pubmed.ncbi.nlm.nih.gov/32614067
Autor:
Francisco Martínez-Ricarte, Manuel Toledo, Elena Fonseca, Andreu Vilaseca-Jolonch, Esteban Cordero, Manuel Quintana, Laura Abraira, Estevo Santamarina, Vanessa Thonon, María Sueiras, Javier Salas-Puig
Publikováno v:
Epilepsy & Behavior. 111:107291
Introduction Tumor-associated status epilepticus (TASE) follows a relatively benign course compared with SE in the general population. Little, however, is known about associated prognostic factors. Methods We conducted a prospective, observational st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27987c989d3502abcbd3a9dbf8b61e90
https://doi.org/10.1016/j.yebeh.2020.107291
https://doi.org/10.1016/j.yebeh.2020.107291